HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pengfei Hu Selected Research

FR 180204

1/2020Reactivation of NR4A1 Restrains Chondrocyte Inflammation and Ameliorates Osteoarthritis in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pengfei Hu Research Topics

Disease

7Inflammation (Inflammations)
01/2020 - 04/2012
6Neoplasms (Cancer)
08/2020 - 01/2014
4Reperfusion Injury
01/2021 - 01/2018
4Osteoarthritis
01/2020 - 01/2014
3Pathologic Constriction (Stenosis)
12/2021 - 01/2016
3Cardiotoxicity
01/2021 - 01/2018
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 01/2020
2Sepsis (Septicemia)
01/2020 - 08/2019
2Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 01/2018
2Infarction (Infarctions)
01/2019 - 03/2017
2Cicatrix (Scar)
01/2019 - 03/2017
2Myocardial Infarction
01/2018 - 08/2017
1Stroke (Strokes)
12/2021
1Vertebrobasilar Insufficiency
12/2021
1Glioma (Gliomas)
08/2020
1Synostosis
07/2020
1Hypertension (High Blood Pressure)
03/2020
1Adenocarcinoma of Lung
03/2020
1Neoplasm Metastasis (Metastasis)
03/2020
1Ischemia
01/2020
1Joint Diseases (Joint Disease)
01/2020
1Tuberculosis (Tuberculoses)
05/2019
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2018
1Chronic Kidney Failure (Chronic Renal Failure)
10/2018
1Ischemic Stroke
10/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
10/2018
1Essential Hypertension
10/2018
1Diabetic Cardiomyopathies
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Hyperemia
01/2016
1Atherosclerosis
04/2012
1Atherosclerotic Plaque (Atheroma)
04/2012

Drug/Important Bio-Agent (IBA)

3Long Noncoding RNAIBA
01/2021 - 01/2020
3MicroRNAs (MicroRNA)IBA
01/2021 - 08/2019
3RNA (Ribonucleic Acid)IBA
01/2021 - 01/2020
2BESIBA
12/2021 - 01/2016
2LuciferasesIBA
01/2021 - 01/2020
2trans-sodium crocetinate (crocetin)IBA
01/2020 - 01/2020
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 03/2017
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2019 - 03/2017
1Proteins (Proteins, Gene)FDA Link
08/2020
1Thyroid HormonesIBA
08/2020
1human MIRN124 microRNAIBA
03/2020
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
03/2020
1SincalideFDA Link
01/2020
1Orphan Nuclear ReceptorsIBA
01/2020
1Metalloproteases (Metalloproteinases)IBA
01/2020
1LipopolysaccharidesIBA
01/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020
1SB 203580IBA
01/2020
1Matrix Metalloproteinases (MMPs)IBA
01/2020
1pyrazolanthroneIBA
01/2020
1ThrombospondinsIBA
01/2020
1DisintegrinsIBA
01/2020
1FR 180204IBA
01/2020
1cytosporone BIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
12/2019
1Interleukin-6 (Interleukin 6)IBA
08/2019
1Cell Adhesion MoleculesIBA
05/2019
1Sorting NexinsIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1renalaseIBA
10/2018
1KetonesIBA
01/2018
1AntioxidantsIBA
01/2018
1schizandrin BIBA
01/2018
12',3',4',5'- tetrahydroxystilbene- 2- O- beta- D- glucosideIBA
01/2018
1CalciumIBA
01/2018
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2018
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
08/2017
1N-myc downstream-regulated gene 1 proteinIBA
05/2017
1TensinsIBA
03/2017
1Bromodeoxyuridine (BrdU)IBA
03/2017
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2017
1cordycepinIBA
01/2014
1LipidsIBA
04/2012
1Advanced Glycation End ProductsIBA
04/2012

Therapy/Procedure

3Stents
12/2021 - 01/2016
3Therapeutics
03/2020 - 01/2016
1Osteotomy
07/2020
1Intra-Articular Injections
01/2020
1Photothermal Therapy
10/2017
1Bloodletting
01/2016